Login

Switch On Your HIV Smarts.

New research: Is Descovy a new option for PrEP?

New research: Is Descovy a new option for PrEP?

, by Chris Hall, MD

Exciting results about a candidate PrEP medication were shared at CROI this week. Read More

New research: Awareness, perceived effectiveness of U=U and intermittent PrEP low among MSM in New York City

New research: Awareness, perceived effectiveness of U=U and intermittent PrEP low among MSM in New York City

, by Emily Land

Is everyone getting accurate information about PrEP and what it means to be undetectable? New research says there’s still work to be done. Read More

For people having anal sex, PrEP 211 is as effective as daily PrEP

For people having anal sex, PrEP 211 is as effective as daily PrEP

, by Emily Land

PrEP 211 allows greater flexibility of dosing—and is just as effective as PrEP taken daily. Read More

Sixth case of rare PrEP failure reported—here’s what to know.

Sixth case of rare PrEP failure reported—here’s what to know.

, by Emily Land

A case of PrEP failure due to transmitted drug resistance was reported at IDWeek 2018. Chris Hall, MD shares what this means for people currently taking PrEP. Read More

PrEP use since 2012 is up, but uptake falls short of need

PrEP use since 2012 is up, but uptake falls short of need

, by Liz Highleyman

1.45 million Americans may be at substantial risk for HIV infection, but only 8% are taking PrEP. Women, people of color, and southern regions are underrepresented. Read More